The Orphan Drug Act revolutionized rare disease treatment, yet rising costs and access issues challenge equitable health care solutions.
Hosted on MSN
What Is Coinsurance?
Coinsurance is the percentage of a medical bill that you’re responsible for after you’ve met your deductible. Think of it as an agreement with your insurance company to share costs: You each pay a ...
Systemic And Structural Racism: Definitions, Examples, Health Damages, And Approaches To Dismantling
Gilbert Gee and Annie Ro depict systemic racism as the hidden base of an iceberg 10 (see illustration in online appendix exhibit 1). 11 The iceberg’s visible part represents the overt racism that ...
Danone North Europe has urged policymakers to work with industry, NGOs and health professionals to provide consumers with a clear definition of healthy food. Research from Danone’s inaugural report, ...
Imad was a senior reporter covering Google and internet culture. Hailing from Texas, Imad started his journalism career in 2013 and has amassed bylines with The New York Times, The Washington Post, ...
This is the first of several alerts that Groom Law Group expects to issue regarding the new proposed regulation issued on January 29, 2026 by the ...
As the Government prepares to consult on widening the scope of foods considered high in fat, salt and sugar (HFSS), Danone North Europe is urging policymakers to work with industry, NGOs and health ...
We analyzed nearly 720 health insurance costs from eight insurers, reviewed complaints, customer satisfaction, metal tiers and the types of plans offered in the marketplace. See our top picks below to ...
With the healthcare affordability and insurance premiums in particular in the headlines, a new report finds that while the employer-sponsored space is largely stable, declines continue among smaller ...
It's becoming increasingly impossible to ignore AI in our everyday lives. That doesn't mean it's always easy to understand. From agentic AI to UBI, tech CEOs, Wall Street, and politicians increasingly ...
Twenty years after the introduction of the theory, we revisit what it does—and doesn’t—explain. by Clayton M. Christensen, Michael E. Raynor and Rory McDonald Please enjoy this HBR Classic. Clayton M.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results